CANIVERM tableta 0,175 g, za pse i mačke
CANIVERM tableta 0,175 g, za pse i mačke
Authorised
- Praziquantel
- Pyrantel embonate
- Fenbendazole
Product identification
Medicine name:
CANIVERM tableta 0,175 g, za pse i mačke
Active substance:
- Praziquantel
- Pyrantel embonate
- Fenbendazole
Target species:
-
Dog
-
Cat
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Praziquantel12.50/milligram(s)0.18gram(s)
-
Pyrantel embonate36.00/milligram(s)0.18gram(s)
-
Fenbendazole37.50/milligram(s)0.18gram(s)
Pharmaceutical form:
-
Tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP52AC30
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Croatia
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Bioveta a.s.
Marketing authorisation date:
Manufacturing sites for batch release:
- Bioveta a.s.
Responsible authority:
- Croatian Veterinary Institute
Authorisation number:
- UP/I-322-05/18-01/175
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Croatian (PDF)
Published on: 10/02/2022
Updated on: 14/03/2026